| Treatment groups |
Baseline RQLQ |
RQLQ at the end of 2-week study |
Mean change from baseline |
Mean percentage change from baseline |
Statistical analysis |
| Group A (Levocetirizine 5 mg) |
4.17 ± 0.5 |
3.59 ± 0.33 |
- 0.58 ± 0.31 |
- 13.91% |
p<0.001, highly significant |
| Group B (Desloratidine 5 mg) |
4.27 ± 0.63 |
3.76 ± 0.49 |
- 0.50 ± 0.29 |
- 11.71% |
p<0.001, highly significant |
